 | • レポートコード：QYR2104Z0524 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、自己免疫治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（関節リウマチ（RA）、多発性硬化症（MS）、乾癬、炎症性腸疾患（IBD）、強直性脊椎炎（AS）、全身性エリテマトーデス（SLE））、用途別市場規模（病院、在宅医療、専門クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・自己免疫治療薬の市場動向 ・企業の競争状況、市場シェア ・自己免疫治療薬の種類別市場規模（関節リウマチ（RA）、多発性硬化症（MS）、乾癬、炎症性腸疾患（IBD）、強直性脊椎炎（AS）、全身性エリテマトーデス（SLE）） ・自己免疫治療薬の用途別市場規模（病院、在宅医療、専門クリニック） ・自己免疫治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・自己免疫治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・自己免疫治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・自己免疫治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・自己免疫治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly、GSK、AbbVie、Johnson & Johnson、Biogen、Amgen、Pfizer、Roche、Baxter） ・結論 |
Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.
Market Analysis and Insights: Global Autoimmune Drugs Market
The global Autoimmune Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autoimmune Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autoimmune Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autoimmune Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autoimmune Drugs market.
Global Autoimmune Drugs Scope and Market Size
Autoimmune Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
Psoriasis
Inflammatory Bowel Disease (IBD)
Ankylosing Spondylitis (AS)
Systemic Lupus Erythematosus (SLE)
Segment by Application
Hospitals
Homecare Settings
Specialty Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eli Lilly
GSK
AbbVie
Johnson & Johnson
Biogen
Amgen
Pfizer
Roche
Baxter
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Rheumatoid Arthritis (RA)
1.2.3 Multiple Sclerosis (MS)
1.2.4 Psoriasis
1.2.5 Inflammatory Bowel Disease (IBD)
1.2.6 Ankylosing Spondylitis (AS)
1.2.7 Systemic Lupus Erythematosus (SLE)
1.3 Market by Application
1.3.1 Global Autoimmune Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Homecare Settings
1.3.4 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Drugs Market Perspective (2016-2027)
2.2 Autoimmune Drugs Growth Trends by Regions
2.2.1 Autoimmune Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autoimmune Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Autoimmune Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Autoimmune Drugs Industry Dynamic
2.3.1 Autoimmune Drugs Market Trends
2.3.2 Autoimmune Drugs Market Drivers
2.3.3 Autoimmune Drugs Market Challenges
2.3.4 Autoimmune Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Drugs Players by Revenue
3.1.1 Global Top Autoimmune Drugs Players by Revenue (2016-2021)
3.1.2 Global Autoimmune Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Drugs Revenue
3.4 Global Autoimmune Drugs Market Concentration Ratio
3.4.1 Global Autoimmune Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Drugs Revenue in 2020
3.5 Autoimmune Drugs Key Players Head office and Area Served
3.6 Key Players Autoimmune Drugs Product Solution and Service
3.7 Date of Enter into Autoimmune Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Drugs Breakdown Data by Type
4.1 Global Autoimmune Drugs Historic Market Size by Type (2016-2021)
4.2 Global Autoimmune Drugs Forecasted Market Size by Type (2022-2027)
5 Autoimmune Drugs Breakdown Data by Application
5.1 Global Autoimmune Drugs Historic Market Size by Application (2016-2021)
5.2 Global Autoimmune Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Autoimmune Drugs Market Size (2016-2027)
6.2 North America Autoimmune Drugs Market Size by Type
6.2.1 North America Autoimmune Drugs Market Size by Type (2016-2021)
6.2.2 North America Autoimmune Drugs Market Size by Type (2022-2027)
6.2.3 North America Autoimmune Drugs Market Size by Type (2016-2027)
6.3 North America Autoimmune Drugs Market Size by Application
6.3.1 North America Autoimmune Drugs Market Size by Application (2016-2021)
6.3.2 North America Autoimmune Drugs Market Size by Application (2022-2027)
6.3.3 North America Autoimmune Drugs Market Size by Application (2016-2027)
6.4 North America Autoimmune Drugs Market Size by Country
6.4.1 North America Autoimmune Drugs Market Size by Country (2016-2021)
6.4.2 North America Autoimmune Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Autoimmune Drugs Market Size (2016-2027)
7.2 Europe Autoimmune Drugs Market Size by Type
7.2.1 Europe Autoimmune Drugs Market Size by Type (2016-2021)
7.2.2 Europe Autoimmune Drugs Market Size by Type (2022-2027)
7.2.3 Europe Autoimmune Drugs Market Size by Type (2016-2027)
7.3 Europe Autoimmune Drugs Market Size by Application
7.3.1 Europe Autoimmune Drugs Market Size by Application (2016-2021)
7.3.2 Europe Autoimmune Drugs Market Size by Application (2022-2027)
7.3.3 Europe Autoimmune Drugs Market Size by Application (2016-2027)
7.4 Europe Autoimmune Drugs Market Size by Country
7.4.1 Europe Autoimmune Drugs Market Size by Country (2016-2021)
7.4.2 Europe Autoimmune Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Drugs Market Size (2016-2027)
8.2 Asia-Pacific Autoimmune Drugs Market Size by Type
8.2.1 Asia-Pacific Autoimmune Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autoimmune Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autoimmune Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Autoimmune Drugs Market Size by Application
8.3.1 Asia-Pacific Autoimmune Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autoimmune Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autoimmune Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Autoimmune Drugs Market Size by Region
8.4.1 Asia-Pacific Autoimmune Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autoimmune Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Autoimmune Drugs Market Size (2016-2027)
9.2 Latin America Autoimmune Drugs Market Size by Type
9.2.1 Latin America Autoimmune Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Autoimmune Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Autoimmune Drugs Market Size by Type (2016-2027)
9.3 Latin America Autoimmune Drugs Market Size by Application
9.3.1 Latin America Autoimmune Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Autoimmune Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Autoimmune Drugs Market Size by Application (2016-2027)
9.4 Latin America Autoimmune Drugs Market Size by Country
9.4.1 Latin America Autoimmune Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Autoimmune Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Drugs Market Size (2016-2027)
10.2 Middle East & Africa Autoimmune Drugs Market Size by Type
10.2.1 Middle East & Africa Autoimmune Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autoimmune Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autoimmune Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Autoimmune Drugs Market Size by Application
10.3.1 Middle East & Africa Autoimmune Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autoimmune Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autoimmune Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Autoimmune Drugs Market Size by Country
10.4.1 Middle East & Africa Autoimmune Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autoimmune Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Autoimmune Drugs Introduction
11.1.4 Eli Lilly Revenue in Autoimmune Drugs Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Autoimmune Drugs Introduction
11.2.4 GSK Revenue in Autoimmune Drugs Business (2016-2021)
11.2.5 GSK Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Autoimmune Drugs Introduction
11.3.4 AbbVie Revenue in Autoimmune Drugs Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Autoimmune Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Autoimmune Drugs Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Biogen
11.5.1 Biogen Company Details
11.5.2 Biogen Business Overview
11.5.3 Biogen Autoimmune Drugs Introduction
11.5.4 Biogen Revenue in Autoimmune Drugs Business (2016-2021)
11.5.5 Biogen Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Autoimmune Drugs Introduction
11.6.4 Amgen Revenue in Autoimmune Drugs Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Autoimmune Drugs Introduction
11.7.4 Pfizer Revenue in Autoimmune Drugs Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Autoimmune Drugs Introduction
11.8.4 Roche Revenue in Autoimmune Drugs Business (2016-2021)
11.8.5 Roche Recent Development
11.9 Baxter
11.9.1 Baxter Company Details
11.9.2 Baxter Business Overview
11.9.3 Baxter Autoimmune Drugs Introduction
11.9.4 Baxter Revenue in Autoimmune Drugs Business (2016-2021)
11.9.5 Baxter Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Autoimmune Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Rheumatoid Arthritis (RA)
Table 3. Key Players of Multiple Sclerosis (MS)
Table 4. Key Players of Psoriasis
Table 5. Key Players of Inflammatory Bowel Disease (IBD)
Table 6. Key Players of Ankylosing Spondylitis (AS)
Table 7. Key Players of Systemic Lupus Erythematosus (SLE)
Table 8. Global Autoimmune Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Autoimmune Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Autoimmune Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Autoimmune Drugs Market Share by Regions (2016-2021)
Table 12. Global Autoimmune Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Autoimmune Drugs Market Share by Regions (2022-2027)
Table 14. Autoimmune Drugs Market Trends
Table 15. Autoimmune Drugs Market Drivers
Table 16. Autoimmune Drugs Market Challenges
Table 17. Autoimmune Drugs Market Restraints
Table 18. Global Autoimmune Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Autoimmune Drugs Market Share by Players (2016-2021)
Table 20. Global Top Autoimmune Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Drugs as of 2020)
Table 21. Ranking of Global Top Autoimmune Drugs Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Autoimmune Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Autoimmune Drugs Product Solution and Service
Table 25. Date of Enter into Autoimmune Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Autoimmune Drugs Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Autoimmune Drugs Revenue Market Share by Type (2016-2021)
Table 29. Global Autoimmune Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Autoimmune Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Autoimmune Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Autoimmune Drugs Revenue Market Share by Application (2016-2021)
Table 33. Global Autoimmune Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Autoimmune Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Autoimmune Drugs Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Autoimmune Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Autoimmune Drugs Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Autoimmune Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Autoimmune Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Autoimmune Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Autoimmune Drugs Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Autoimmune Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Autoimmune Drugs Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Autoimmune Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Autoimmune Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Autoimmune Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Autoimmune Drugs Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Autoimmune Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Autoimmune Drugs Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Autoimmune Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Autoimmune Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Autoimmune Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Autoimmune Drugs Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Autoimmune Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Autoimmune Drugs Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Autoimmune Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Autoimmune Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Autoimmune Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Autoimmune Drugs Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Autoimmune Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Autoimmune Drugs Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Autoimmune Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Autoimmune Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Autoimmune Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 65. Eli Lilly Company Details
Table 66. Eli Lilly Business Overview
Table 67. Eli Lilly Autoimmune Drugs Product
Table 68. Eli Lilly Revenue in Autoimmune Drugs Business (2016-2021) & (US$ Million)
Table 69. Eli Lilly Recent Development
Table 70. GSK Company Details
Table 71. GSK Business Overview
Table 72. GSK Autoimmune Drugs Product
Table 73. GSK Revenue in Autoimmune Drugs Business (2016-2021) & (US$ Million)
Table 74. GSK Recent Development
Table 75. AbbVie Company Details
Table 76. AbbVie Business Overview
Table 77. AbbVie Autoimmune Drugs Product
Table 78. AbbVie Revenue in Autoimmune Drugs Business (2016-2021) & (US$ Million)
Table 79. AbbVie Recent Development
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Autoimmune Drugs Product
Table 83. Johnson & Johnson Revenue in Autoimmune Drugs Business (2016-2021) & (US$ Million)
Table 84. Johnson & Johnson Recent Development
Table 85. Biogen Company Details
Table 86. Biogen Business Overview
Table 87. Biogen Autoimmune Drugs Product
Table 88. Biogen Revenue in Autoimmune Drugs Business (2016-2021) & (US$ Million)
Table 89. Biogen Recent Development
Table 90. Amgen Company Details
Table 91. Amgen Business Overview
Table 92. Amgen Autoimmune Drugs Product
Table 93. Amgen Revenue in Autoimmune Drugs Business (2016-2021) & (US$ Million)
Table 94. Amgen Recent Development
Table 95. Pfizer Company Details
Table 96. Pfizer Business Overview
Table 97. Pfizer Autoimmune Drugs Product
Table 98. Pfizer Revenue in Autoimmune Drugs Business (2016-2021) & (US$ Million)
Table 99. Pfizer Recent Development
Table 100. Roche Company Details
Table 101. Roche Business Overview
Table 102. Roche Revenue in Autoimmune Drugs Business (2016-2021) & (US$ Million)
Table 103. Roche Recent Development
Table 104. Baxter Company Details
Table 105. Baxter Business Overview
Table 106. Baxter Autoimmune Drugs Product
Table 107. Baxter Revenue in Autoimmune Drugs Business (2016-2021) & (US$ Million)
Table 108. Baxter Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Drugs Market Share by Type: 2020 VS 2027
Figure 2. Rheumatoid Arthritis (RA) Features
Figure 3. Multiple Sclerosis (MS) Features
Figure 4. Psoriasis Features
Figure 5. Inflammatory Bowel Disease (IBD) Features
Figure 6. Ankylosing Spondylitis (AS) Features
Figure 7. Systemic Lupus Erythematosus (SLE) Features
Figure 8. Global Autoimmune Drugs Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Homecare Settings Case Studies
Figure 11. Specialty Clinics Case Studies
Figure 12. Autoimmune Drugs Report Years Considered
Figure 13. Global Autoimmune Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Autoimmune Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Autoimmune Drugs Market Share by Regions: 2020 VS 2027
Figure 16. Global Autoimmune Drugs Market Share by Regions (2022-2027)
Figure 17. Global Autoimmune Drugs Market Share by Players in 2020
Figure 18. Global Top Autoimmune Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Drugs as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Autoimmune Drugs Revenue in 2020
Figure 20. Global Autoimmune Drugs Revenue Market Share by Type (2016-2021)
Figure 21. Global Autoimmune Drugs Revenue Market Share by Type (2022-2027)
Figure 22. North America Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Autoimmune Drugs Market Share by Type (2016-2027)
Figure 24. North America Autoimmune Drugs Market Share by Application (2016-2027)
Figure 25. North America Autoimmune Drugs Market Share by Country (2016-2027)
Figure 26. United States Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Autoimmune Drugs Market Share by Type (2016-2027)
Figure 30. Europe Autoimmune Drugs Market Share by Application (2016-2027)
Figure 31. Europe Autoimmune Drugs Market Share by Country (2016-2027)
Figure 32. Germany Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Autoimmune Drugs Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Autoimmune Drugs Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Autoimmune Drugs Market Share by Region (2016-2027)
Figure 42. China Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Autoimmune Drugs Market Share by Type (2016-2027)
Figure 50. Latin America Autoimmune Drugs Market Share by Application (2016-2027)
Figure 51. Latin America Autoimmune Drugs Market Share by Country (2016-2027)
Figure 52. Mexico Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Autoimmune Drugs Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Autoimmune Drugs Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Autoimmune Drugs Market Share by Country (2016-2027)
Figure 58. Turkey Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Autoimmune Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Eli Lilly Revenue Growth Rate in Autoimmune Drugs Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in Autoimmune Drugs Business (2016-2021)
Figure 63. AbbVie Revenue Growth Rate in Autoimmune Drugs Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Autoimmune Drugs Business (2016-2021)
Figure 65. Biogen Revenue Growth Rate in Autoimmune Drugs Business (2016-2021)
Figure 66. Amgen Revenue Growth Rate in Autoimmune Drugs Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Autoimmune Drugs Business (2016-2021)
Figure 68. Roche Revenue Growth Rate in Autoimmune Drugs Business (2016-2021)
Figure 69. Baxter Revenue Growth Rate in Autoimmune Drugs Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の全身性自己免疫疾患診断市場 2021：企業別、地域別、種類・用途別 The Systemic Autoimmune Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 世界の強直性脊椎炎治療市場規模・現状・予測（2021年-2027年） Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and p…
- 世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autoimmune Disease Therapeutics Market The global Autoimmune Disease Therapeutics market size is projected to reach US$ 116550 million by 2026, from US$ 98660 million in 2019, at a CAGR of 2.4% during 2021-2026. With industry-standard accuracy in analysis and hig…
- 世界の炎症性腸疾患治療薬市場 2021：企業別、地域別、種類・用途別 The Inflammatory Bowel Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Autoimmune diseases is a body’s hyperactive immune response against the substances and tissues normally present in the body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors. Market Analysis and Insights: Global Autoimmune Disease Treatment Market The glob…